Please login to the form below

Not currently logged in
Email:
Password:

ADRs 'significantly under-reported', says BMA

Over 250,000 UK patients admitted to hospital every year suffering from drug reactions

Adverse drug reactions are `significantly under-reported' in the UK and doctors are often confused about how to inform regulators of suspected side effects, according to a new British Medical Association (BMA) report.

The study, Reporting Adverse Drug Reactions: A guide for healthcare professionals says that at least 250,000 UK patients are admitted to hospital suffering from adverse drug reactions at a cost of some £466m a year.

It also calls on health professionals to inform the Medicines and Healthcare products Regulatory Agency (MHRA) when a medication has an unwanted effect.

Dr Vivienne Nathanson, head of BMA ethics and science, said doctors had a professional duty to report all adverse drug reactions, especially if children or the elderly are involved.

ìUnfortunately too many health professionals are confused about reporting procedures,î she said. ìDoctors must make sure they report any suspected ADR and at the same time increase awareness among their patients about the reporting process.î

She added that only about 10 per cent of adverse reactions are formally reported.

According to a 2004 study, 6.5 per cent of people admitted to a hospital had suffered an ADR and in 80 per cent of these cases, the reaction was the cause of the admission.

The report says reporting rates must be increased and cites how in 2003, ADR reporting of its effects on the liver caused the herbal drug kava kava to be withdrawn.

The report also recommends ways in which health professionals can increase reporting rates. These include stricter vigilance of so-called `black triangle' labelled drugs, which are under intensive monitoring, and making patients aware that they should immediately inform their doctor if they suffer any reaction to a medicine.

While ADR reporting has traditionally been the domain of doctors, pharmacists and nurses, at the tail end of last year the MHRA announced a scheme whereby patients were able to report drug side effects to the regulator.

'Yellow card' forms were placed in GP practices and other NHS sites; patients are also able to report suspected side effects online at www.yellowcard.gov.uk.

30th September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics